Change in visual function after macular translocation with 360° retinectomy for neovascular age-related macular degeneration
- 30 September 2004
- journal article
- Published by Elsevier BV in Ophthalmology
- Vol. 111 (9), 1715-1724
- https://doi.org/10.1016/j.ophtha.2004.03.022
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomesOphthalmology, 2003
- Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1American Journal of Ophthalmology, 2003
- Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfinOphthalmology, 2003
- Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degenerationOphthalmology, 2003
- ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD)Published by Ovid Technologies (Wolters Kluwer Health) ,2003
- MACULAR TRANSLOCATION WITH 360-DEGREE PERIPHERAL RETINECTOMYRetina, 2001
- Loss of Visual Acuity is the Main Reason Why Reading Addition Increases After the Age of SixtyOptometry and Vision Science, 2001
- Macular translocationOphthalmology, 2000
- Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degenerationOphthalmology, 1999
- Macular TranslocationAmerican Journal of Ophthalmology, 1998